These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16957451)

  • 1. Age-related structural changes in cardiac valves: implications for tissue-engineered repairs.
    Barzilla JE; Blevins TL; Grande-Allen KJ
    Am J Geriatr Cardiol; 2006; 15(5):311-5. PubMed ID: 16957451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart valve tissue engineering.
    Neuenschwander S; Hoerstrup SP
    Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts.
    Emmert MY; Weber B; Behr L; Sammut S; Frauenfelder T; Wolint P; Scherman J; Bettex D; Grünenfelder J; Falk V; Hoerstrup SP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):61-8. PubMed ID: 23657551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human or animal homograft: could they have a future as a biological scaffold for engineered heart valves?
    Dainese L; Biglioli P
    J Cardiovasc Surg (Torino); 2010 Jun; 51(3):449-56. PubMed ID: 20523298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineering challenges for heart valve tissue engineering.
    Sacks MS; Schoen FJ; Mayer JE
    Annu Rev Biomed Eng; 2009; 11():289-313. PubMed ID: 19413511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
    Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
    Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Special Issue on Heart Valve Mechanobiology : New Insights into Mechanical Regulation of Valve Disease and Regeneration.
    Simmons CA; Jo H
    Cardiovasc Eng Technol; 2018 Jun; 9(2):121-125. PubMed ID: 29761407
    [No Abstract]   [Full Text] [Related]  

  • 9. Developing a Clinically Relevant Tissue Engineered Heart Valve-A Review of Current Approaches.
    Nachlas ALY; Li S; Davis ME
    Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29171921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status of Tissue Engineering Heart Valve.
    Shinoka T; Miyachi H
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-Engineered Heart Valves: A Call for Mechanistic Studies.
    Blum KM; Drews JD; Breuer CK
    Tissue Eng Part B Rev; 2018 Jun; 24(3):240-253. PubMed ID: 29327671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves.
    Dijkman PE; Driessen-Mol A; de Heer LM; Kluin J; van Herwerden LA; Odermatt B; Baaijens FP; Hoerstrup SP
    J Heart Valve Dis; 2012 Sep; 21(5):670-8. PubMed ID: 23167234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue engineering of autologous heart valves: a focused update.
    Le Huu A; Shum-Tim D
    Future Cardiol; 2014 Jan; 10(1):93-104. PubMed ID: 24344666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomechanical properties of native and tissue engineered heart valve constructs.
    Hasan A; Ragaert K; Swieszkowski W; Selimović S; Paul A; Camci-Unal G; Mofrad MR; Khademhosseini A
    J Biomech; 2014 Jun; 47(9):1949-63. PubMed ID: 24290137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering.
    Schoen FJ
    Circulation; 2008 Oct; 118(18):1864-80. PubMed ID: 18955677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves.
    James IA; Yi T; Tara S; Best CA; Stuber AJ; Shah KV; Austin BF; Sugiura T; Lee YU; Lincoln J; Trask AJ; Shinoka T; Breuer CK
    Tissue Eng Part C Methods; 2015 Sep; 21(9):987-94. PubMed ID: 25915105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering natural heart valves: possibilities and challenges.
    Namiri M; Ashtiani MK; Mashinchian O; Hasani-Sadrabadi MM; Mahmoudi M; Aghdami N; Baharvand H
    J Tissue Eng Regen Med; 2017 May; 11(5):1675-1683. PubMed ID: 26799729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of valve geometry and tissue anisotropy on the radial stretch and coaptation area of tissue-engineered heart valves.
    Loerakker S; Argento G; Oomens CW; Baaijens FP
    J Biomech; 2013 Jul; 46(11):1792-800. PubMed ID: 23786664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing Biocompatible Tissue Engineered Heart Valves In Situ: JACC Review Topic of the Week.
    Cordoves EM; Vunjak-Novakovic G; Kalfa DM
    J Am Coll Cardiol; 2023 Mar; 81(10):994-1003. PubMed ID: 36889879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.